Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities.
Nat Commun
; 11(1): 3288, 2020 07 03.
Article
in En
| MEDLINE
| ID: mdl-32620753
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Biomarkers, Tumor
/
Glioblastoma
/
Proteomics
/
Proteogenomics
/
Isocitrate Dehydrogenase
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Nat Commun
Journal subject:
BIOLOGIA
/
CIENCIA
Year:
2020
Document type:
Article
Country of publication:
United kingdom